Parnasa Mediworld Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.20 Cr
- Revenue Growth 71.08%
- Profit Growth 61.55%
- Ebitda 95.42%
- Net Worth 18.12%
- Total Assets 56.18%
About Parnasa Mediworld
Parnasa Mediworld Private Limited (PMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 March 2016 (Eight years and ten months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.20 Cr.
Keshri Mishra and Kanak Mishra serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51397DL2016PTC292781
-
Company No.
292781
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Mar 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Parnasa Mediworld Private Limited offer?
Parnasa Mediworld Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Nutraceuticals & Dietary Supplements, Fitness Supplements, Ayurvedic & Herbal Extracts, Plant Extracts.
Who are the key members and board of directors at Parnasa Mediworld?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanak Mishra
|
Director | 17-Mar-2016 | Current |
|
Keshri Mishra
|
Director | 17-Mar-2016 | Current |
Financial Performance of Parnasa Mediworld.
Parnasa Mediworld Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.08% increase. The company also saw a substantial improvement in profitability, with a 61.55% increase in profit. The company's net worth Soared by an impressive increase of 18.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parnasa Mediworld?
Unlock access to Parnasa Mediworld's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Biomodex Pharmaceuticals Private LimitedKeshri Mishra is a mutual person
Charges (Loans)
₹21.96 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.37 Cr
- Hdfc Bank Limited : 0.49 Cr
- Axis Bank Limited : 0.34 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2024 | Hdfc Bank Limited | ₹4.86 M | Open |
| 28 Sep 2022 | Axis Bank Limited | ₹3.41 M | Open |
| 11 Jul 2022 | Others | ₹1.20 Cr | Open |
| 18 Jan 2020 | Others | ₹1.70 M | Open |
How Many Employees Work at Parnasa Mediworld?
Parnasa Mediworld has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parnasa Mediworld, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parnasa Mediworld's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
